• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Personalis, Inc. - Common Stock (NQ:PSNL)

    11.41 +1.76 (+18.24%)
    Streaming Delayed Price Updated: 3:40 PM EST, Jan 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,605,321
    Open 9.710
    Bid (Size) 11.40 (200)
    Ask (Size) 11.42 (2,000)
    Prev. Close 9.650
    Today's Range 9.710 - 11.50
    52wk Range 2.826 - 11.40
    Shares Outstanding 48,518,901
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights
    From Personalis, Inc.
    Via Business Wire

    Performance

    YTD
    +45.4%
    +45.4%
    1 Month
    +30.8%
    +30.8%
    3 Month
    +27.8%
    +27.8%
    6 Month
    +68.8%
    +68.8%
    1 Year
    +105.6%
    +105.6%

    More News

    Read More
    News headline image
    Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday ↗
    Via Benzinga
    News headline image
    Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer
    From Personalis, Inc.
    Via Business Wire
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    Personalis Reports Third Quarter 2025 Financial Results
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Announce Third Quarter 2025 Financial Results
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Personalis, Inc.
    Via Business Wire
    News headline image
    CATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal Test
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing
    From Personalis, Inc.
    Via Business Wire
    News headline image
    Personalis to Participate in Upcoming Investor Conferences
    From Personalis, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    The market is filled with gapping stocks in Wednesday's session. ↗
    Via Chartmill
    News headline image
    Discover the top movers in Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Personalis (PSNL) Q2 Revenue Falls 24% ↗
    Via The Motley Fool
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Personalis, Inc. - Common Stock publicly traded?
    Yes, Personalis, Inc. - Common Stock is publicly traded.
    What exchange does Personalis, Inc. - Common Stock trade on?
    Personalis, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Personalis, Inc. - Common Stock?
    The ticker symbol for Personalis, Inc. - Common Stock is PSNL on the Nasdaq Stock Market
    What is the current price of Personalis, Inc. - Common Stock?
    The current price of Personalis, Inc. - Common Stock is 11.41
    When was Personalis, Inc. - Common Stock last traded?
    The last trade of Personalis, Inc. - Common Stock was at 01/22/26 03:40 PM ET
    What is the market capitalization of Personalis, Inc. - Common Stock?
    The market capitalization of Personalis, Inc. - Common Stock is 553.60M
    How many shares of Personalis, Inc. - Common Stock are outstanding?
    Personalis, Inc. - Common Stock has 554M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.